Pati D

References (2)

Title : StagX1, an isoquinolinone compound, selectively targets CES1-positive Ewing sarcoma cells as a potential therapeutic agent - Zhang_2026_Mol.Ther.Oncol_34_201321
Author(s) : Zhang N , Gilbertson SR , Li F , Pati D
Ref : Mol Ther Oncol , 34 :201321 , 2026
Abstract :
PubMedSearch : Zhang_2026_Mol.Ther.Oncol_34_201321
PubMedID: 42668658

Title : Synthesis and Evaluation of a Class of Compounds Inhibiting the Growth of Stromal Antigen 2 (STAG2)-Mutant Ewing Sarcoma Cells - Zhang_2022_ChemMedChem_17_e202100653
Author(s) : Zhang N , Lin KF , Yang C , Peruski S , Pati D , Gilbertson SR
Ref : ChemMedChem , 17 :e202100653 , 2022
Abstract :
PubMedSearch : Zhang_2022_ChemMedChem_17_e202100653
PubMedID: 35018729